Development of a customizable mouse backbone spectral flow cytometry panel to delineate immune cell populations in normal and tumor tissues
ALF Longhini, I Fernández-Maestre… - Frontiers in …, 2024 - frontiersin.org
Introduction In vivo studies of cancer biology and assessment of therapeutic efficacy are
critical to advancing cancer research and ultimately improving patient outcomes. Murine …
critical to advancing cancer research and ultimately improving patient outcomes. Murine …
Inhibition of Enhancer of Zeste Homolog 2 Induces Blast Differentiation, Impairs Engraftment and Prolongs Survival in Murine Models of Acute Myeloid Leukemia
Simple Summary Acute myeloid leukemia (AML) is the abnormal growth of immature blood
cells characterized by a block in differentiation. The therapy options to treat AML have …
cells characterized by a block in differentiation. The therapy options to treat AML have …
Case report: single-cell RNA sequencing of PBMCs highlights monocyte gene expression alterations in a type A HBV-ACLF patient
Y Wang, Z Hao, J Liu, X Kang, C Ji, Y Guo, Z Chen… - Heliyon, 2024 - cell.com
Hepatitis B Virus-related acute-on-chronic liver failure (HBV-ACLF) is a severe complication
with high fatality rates. However, the underlying mechanisms are still elusive and require …
with high fatality rates. However, the underlying mechanisms are still elusive and require …
[HTML][HTML] Differentiation Therapy in Acute Myeloid Leukemia: Not Just for APL Anymore
PJ Sung - Differentiation, 2024 - quinquelles.cl
A hallmark of acute myeloid leukemia (AML) is a maturation arrest of myeloid-committed
hematopoietic cells, and the specific sensitivity of acute promyelocytic leukemia (APL) to …
hematopoietic cells, and the specific sensitivity of acute promyelocytic leukemia (APL) to …